Anhui Tiankai to construct allulose production lines

    Summary: On 17 May, EIAs of Anhui Tiankai's nutritional supplements healthy industry project and functional and nutritional healthy food project were publicized before approved by the Government of Quanjiao County. Allulose production lines will be built both in these two projects, with a total capacity of 2,500 t/a.   

    On 17 May, Government of Quanjiao County publicised the environmental impact assessments (EIA) of Anhui Tiankai Biotechnology Co., Ltd. (Anhui Tiankai)'s nutritional supplements healthy industry project and functional and nutritional healthy food project for 5 days before grant approval. It is understood that nutritional supplements healthy industry project is regarded as the first phase project and functional and functional and nutritional healthy food project as the second, and they have some overlaps in the workshop layout. Specifically, the EIA of the first phase project has been approved and the construction was started in 2019, but due to changes in the production process of some products and the relocation of the workshops for the second phase project, it was revised. On 23 April, the 2 EIAs were publicised on the official website of the Government of Quanjiao County.   

    Detailed information of the first phase project:   

    
•       Nature: New construction     
    
•       Site: Shitan Industrial Park, Quanjiao County, Anhui Province     
    
•       Total investment: USD30.82 million (RMB200 million), of which environmental protection investment is USD0.38 million (RMB2.45 million)     
    
•       Building area: 37,725 m²     
    
•       Main construction content: Three production plants, in which production lines of functional polysaccharide, DHA & ARA refined oil and microcapsule, probiotics, soft capsule, plant extracts, beverage, biscuits and feed additives, and related storage facilities and living facilities will be constructed.     
    
•       Expected capacity: 1,500 t/a functional polysaccharides (referring to allulose), 900 t/a DHA & ARA refined oil, 300 t/a of DHA, ARA microcapsules, 1,000 t/a probiotics, 30 t/a soft capsules, 100 t/a plant extracts, 1,500 t/a beverages, 500 t/a biscuits and 2,000 t/a feed additives     
    
•       Working system: 200 workers in three shifts for 300 days a year, 7,200 hours in total.     
    

            

    

      As for the second phase project,     

    

            

    
•       Nature: New construction     
    
•       Location: Shitan Industrial Park, Quanjiao County, Anhui Province     
    
•       Total investment: USD77.05 million (RMB500 million), of which USD0.71 million (RMB4.63 million) for environmental protection     
    
•       Floor area: 62,000 m² (93 mu)     
    
•       Main construction content: five production plants, in which production lines of functional sugar, dairy product, special medical food, nutritious food and beverage, functional protein and peptide and functions fermented product, and related storage facilities and supporting environmental protection facilities will be constructed.     
    
•       Expected capacity: 3,000 t/a functional sugar (1,000t/a for allulose and the rest for human milk oligosaccharide), 2,000 t/a dairy products, 1,000 t/a food for special medical purpose, 4,500 t/a nutritious food and beverage, 1,000 t/a functional protein and peptide and 1,100 t/a functional fermented products     
    
•       Working system: 100 workers in three shift, 7,200 hours and 300 days a year.     
    

            

    

      Allulose is a new type of sweetener, which has features of high sweetness and low calories, and it can dissolve in water and  alleviate the rise of blood sugar after eating. Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. is the first enterprise in China to realize the industrial production of allulose by epimerization of fructose. but allulose is currently produced only for export as it has not yet been approved for using as food additive in China.     

    

            

    

      Anhui Tiankai was established in 2018 with a registered capital of USD19.26 million (RMB125 million). Its business include R&D, production, and sales of biological products, food and food additives and pharmaceutical intermediates; R&D, production, sales and services of polymers, and the sales of formula food for special medical porpose, pre-packaged food and bulk food.